![]() |
Name |
Pentacosanoic acid
|
Molecular Formula | C25H50O2 | |
IUPAC Name* |
pentacosanoic acid
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O
|
|
InChI |
InChI=1S/C25H50O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25(26)27/h2-24H2,1H3,(H,26,27)
|
|
InChIKey |
MWMPEAHGUXCSMY-UHFFFAOYSA-N
|
|
Synonyms |
PENTACOSANOIC ACID; 506-38-7; Hyenic acid; n-Pentacosanoic acid; 4S768OX95G; NSC-89289; C25:0; Hyenate; UNII-4S768OX95G; n-Pentacosanoate; pentacosanoic-acid; EINECS 208-036-0; NSC 89289; C24H49COOH; SCHEMBL2054087; CHEMBL4303190; DTXSID8075049; CHEBI:39420; NSC89289; LMFA01010025; MFCD00020551; ZINC32787878; AKOS015839858; FA 25:0; AS-35339; P-NITROPHENYLPHOSPHATETRISBUFFERSALT; HY-124422; CS-0086444; P0882; 562AA15C-C8EA-4109-ABAF-D8CC68CCB7C8; Q4348644
|
|
CAS | 506-38-7 | |
PubChem CID | 10468 | |
ChEMBL ID | CHEMBL4303190 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 382.7 | ALogp: | 11.2 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 23 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 37.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 27 | QED Weighted: | 0.158 |
Caco-2 Permeability: | -5.221 | MDCK Permeability: | 0.00000897 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.231 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.006 | Plasma Protein Binding (PPB): | 98.86% |
Volume Distribution (VD): | 1.717 | Fu: | 0.65% |
CYP1A2-inhibitor: | 0.088 | CYP1A2-substrate: | 0.15 |
CYP2C19-inhibitor: | 0.198 | CYP2C19-substrate: | 0.052 |
CYP2C9-inhibitor: | 0.043 | CYP2C9-substrate: | 0.996 |
CYP2D6-inhibitor: | 0.033 | CYP2D6-substrate: | 0.024 |
CYP3A4-inhibitor: | 0.073 | CYP3A4-substrate: | 0.006 |
Clearance (CL): | 2.802 | Half-life (T1/2): | 0.182 |
hERG Blockers: | 0.235 | Human Hepatotoxicity (H-HT): | 0.015 |
Drug-inuced Liver Injury (DILI): | 0.071 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.011 | Maximum Recommended Daily Dose: | 0.012 |
Skin Sensitization: | 0.959 | Carcinogencity: | 0.028 |
Eye Corrosion: | 0.971 | Eye Irritation: | 0.919 |
Respiratory Toxicity: | 0.818 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000282 | ![]() |
0.885 | D00AOJ | ![]() |
0.768 | ||
ENC000359 | ![]() |
0.841 | D07ILQ | ![]() |
0.551 | ||
ENC000553 | ![]() |
0.820 | D00STJ | ![]() |
0.524 | ||
ENC000433 | ![]() |
0.819 | D0O1PH | ![]() |
0.485 | ||
ENC000724 | ![]() |
0.814 | D00FGR | ![]() |
0.443 | ||
ENC000357 | ![]() |
0.808 | D0Z5SM | ![]() |
0.419 | ||
ENC000434 | ![]() |
0.791 | D05ATI | ![]() |
0.359 | ||
ENC000591 | ![]() |
0.791 | D0XN8C | ![]() |
0.356 | ||
ENC000446 | ![]() |
0.783 | D0P1RL | ![]() |
0.342 | ||
ENC000915 | ![]() |
0.773 | D0Z1QC | ![]() |
0.333 |